| Line Item | 2024-02-23 | Y/Y |
|---|---|---|
| Revenue | $3.16B | -2.3% |
| Cost of Revenue | $2.14B | -7.3% |
| Gross Profit | $1.01B | +10.1% |
| R&D Expense | $48.2M | +8.6% |
| Operating Income | $117.8M | +79.8% |
| Interest Expense | $25.9M | -8.8% |
| Pre-tax Income | $107.1M | +107.6% |
| Income Tax | $26.0M | +59.5% |
| Net Income | $81.1M | +129.7% |
| EPS (Basic) | $0.68 | +126.7% |
| EPS (Diluted) | $0.68 | +126.7% |
| Line Item | 2024-02-23 | Y/Y |
|---|---|---|
| Cash & Equivalents | $318.6M | +252.4% |
| Accounts Receivable | $338.3M | -9.4% |
| Inventory | $231.0M | -27.7% |
| Current Assets | $959.4M | +8.5% |
| Total Assets | $2.24B | +1.5% |
| Current Liabilities | $607.1M | +0.6% |
| Long-term Debt | $446.3M | +0.2% |
| Line Item | 2024-02-23 | Y/Y |
|---|---|---|
| Operating Cash Flow | $308.7M | +245.3% |
| Capital Expenditures | $47.1M | -20.3% |
| Investing Cash Flow | $6.1M | +104.5% |
| Financing Cash Flow | -$85.9M | -36.6% |
| Free Cash Flow | $261.6M | +763.4% |
| Total Liabilities |
| $1.35B |
| -2.0% |
| Stockholders' Equity | $887.1M | +7.4% |